Insulet Corporation
NASDAQ:PODD
| Market Cap (Intraday) | 11.64B |
| Current PE | 56.43 |
| Forward PE | 55.23 |
| 2yr Forward PE | 43.29 |
| 10-Day MA | $169.67 |
| 50-Day MA | $174.51 |
| 200-Day MA | $191.36 |
Insulet Corporation Stock, NASDAQ:PODD
100 Nagog Park, 100 Nagog Park, Acton, Massachusetts 01720
United States of America
Phone: +1.978.600.7000
Number of Employees: 3000
Description
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.